




Cocoa polyphenols and fiber modify colonic gene expression 
in rats
Malen Massot‑Cladera1,2 · Àngels Franch1,2 · Margarida Castell1,2 · 
Francisco J. Pérez‑Cano1,2 
Received: 23 July 2015 / Accepted: 20 May 2016 
© The Author(s) 2016. This article is published with open access at Springerlink.com
Conclusion Most of the effects attributed to cocoa con-
sumption on genes related to the immune system (B cell 
and mast cell functionality) and lipid metabolism in the 
colon tissue were due not only to its fiber content, but 
also to the possible contribution of polyphenols and other 
compounds.
Keywords Cocoa · Colonic gene expression · Dietary 
fiber · Immune function · Lipid metabolism
Introduction
The increasing interest in finding food-based strategies 
with health-improving effects has turned cocoa, the fruit of 
the cocoa tree (Theobroma cacao L.), into one of the sub-
ject matters of study. The health benefits provided by cocoa 
consumption in the prevention of diseases and physiologi-
cal disorders have been described. Thus, cocoa consump-
tion has long been demonstrated to improve cardiovascu-
lar status, decreasing blood pressure and reducing platelet 
aggregation [1, 2]. In addition, cocoa intake has been shown 
to increase HDL cholesterol, to protect against LDL oxida-
tion and to improve hyperlipidemia, insulin sensitivity and 
hyperglycemia [3, 4], and there is emerging evidence of the 
beneficial role of chocolate in reducing body weight/body 
fat [5, 6]. In addition, studies concerning the cocoa protec-
tor effect against carcinogenesis [7], neurodegenerative dis-
eases and cognitive function [8] have also been published.
Preclinical studies have demonstrated that cocoa exerts 
immune modulation in both systemic and intestinal com-
partments [9]. In this context, immunoglobulin production 
is modulated after cocoa intake and, in consequence, cocoa 
has been tested as a possible adjuvant treatment in allergic 
reactions [10]. In addition, the intake of cocoa affects the 
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intestinal compartment by modulating the microbiota, as 
assessed in vivo and clinical studies [11] and also the Toll-
like receptor (TLR) expression, key molecules involved in 
the recognition of microorganisms and inductors of inflam-
matory response [12] both in the inductive and effectors 
intestinal immune tissues, where antigens are sampled lym-
phocytes are activated and where the effector cells contribute 
to the formation of S-IgA antibodies, respectively [13–15].
Whatever the cocoa effect, most of these beneficial 
actions of cocoa have been attributed to its high content of 
polyphenols, mainly flavonoids such as (−)-epicatechin, 
(+)-catechin and their polymeric forms called procyanidins 
[16]. Thus, flavonoids have been related to cocoa-induced 
cardiovascular effects [1, 2], protection against carcinogen-
esis [7], and cognitive function [8]. Nevertheless, it must 
be added that cocoa, besides being a strong source of fla-
vonoids, also has a high content of dietary fiber (26–40 %, 
mostly insoluble fiber) which could strengthen or be in 
part responsible for the effects described above. In general, 
dietary fiber appears to be particularly beneficial against 
various Western diseases, including metabolic syndrome 
[17] and, in particular, cocoa fiber, can prevent obesity by 
reducing body weight and improving glucose levels as well 
as controlling the blood lipid profile and lipid peroxidation 
in animals and human interventions [18].
One of the several possible mechanisms involved in the 
body weight control might be through the cocoa fiber’s 
capacity to increase fat elimination in feces [19, 20] by 
binding bile acids and dietary fats, and interfering with 
lipid absorption in the small intestine [21, 22]. In addition, 
the effects of cocoa fiber assisting in the control of arte-
rial blood pressure in hypercholesterolemic subjects have 
been reviewed [20]. Protection against disorders related to 
the gastrointestinal tract (i.e., constipation, irritable bowel 
syndrome) or colorectal and other types of cancer has also 
been attributed to cocoa fiber fermentation by the colonic 
microbiota which leads to the formation of short chain fatty 
acids (SCFA) [23].
Taking the above evidences together, the influence of 
cocoa consumption on the systemic and intestinal compart-
ments is clear. These effects can be attributed to both its 
polyphenols and fiber content which can reach the colon, but 
also to their microbial metabolites produced after cocoa con-
sumption. Therefore, we hypothesize that important events 
after cocoa intake are produced in the colon environment, 
where bioactive compounds of cocoa would interfere then in 
the gene expression of colon cells. The objective of the pre-
sent work was to study in-depth the mechanisms involved in 
the beneficial effects of cocoa, mainly focused on immune 
system and lipid metabolism modulation, by evaluating 
changes in colonic gene expression after a preclinical nutri-
tional intervention, and to ascertain whether cocoa fiber is 
responsible for these effects. For this purpose, the technique 
chosen is microarray analysis due to the fact that it is a pow-
erful tool that allows global analysis of the expression of 
thousands of genes to be performed in a single assay [24].
Materials and methods
Animals and diets
Female Wistar rats (3 weeks old) were obtained from Jan-
vier (Saint-Berthevin, France) and housed in cages under 
conditions of controlled temperature and humidity in a 
12:12 light–dark cycle. The rats were randomly distrib-
uted into four dietary groups (n = 10/each). The refer-
ence group (REF) was fed with a standard diet AIN-93 M 
(Harlan, Barcelona, Spain); the cocoa group (C10) was 
fed with a diet containing 0.4 % of polyphenols, 0.85 % 
of soluble fiber and 2.55 % of insoluble fiber provided by 
10 % cocoa; the cocoa fiber group (CF) received a diet 
with the same cocoa soluble and insoluble fiber propor-
tion as the C10 group but with a very low amount of poly-
phenols (<0.02 %); and a fourth group (I) received the 
same amount of soluble fiber as the C10 group (0.85 %) 
but in the form of inulin in order to distinguish the par-
ticular effect of cocoa fiber (Table 1). Natural Forastero 
cocoa and cocoa fiber powders [Idilia Foods SL (formerly 
Nutrexpa SL), Barcelona, Spain] with 4.02 and 0.35 % 
of polyphenols, respectively, were used to elaborate the 
C10 and CF diets. Inulin from chicory roots (Fibruline® 
Instant; InnovaFood 2005, S.L, Barcelona, Spain) was 
used as a reference soluble fiber. The three experimental 
diets were elaborated from AIN-93 M formula by sub-
tracting the amount of carbohydrates, proteins, lipids and 
insoluble fibers provided by the corresponding cocoa or 
cocoa fiber extracts. The resulting chows were isoener-
getic and had the same proportion of macronutrients (car-
bohydrates, proteins and lipids) and insoluble fiber as the 
reference diet (Table 1).
Animals were given free access to water and chow. The 
diets lasted for 3 weeks. Studies were performed accord-
ing to the criteria outlined by the Guide for the Care and 
Use of Laboratory Animals. Experimental procedures were 
reviewed and approved by the Ethical Committee for Ani-
mal Experimentation of the University of Barcelona (ref. 
358/12).
Sample collection and preparation
At the end of the 3-week nutritional intervention, the rats 
were anesthetized intramuscularly with ketamine (90 mg/
kg) (Merial Laboratorios, S.A., Barcelona, Spain) and xyla-
zine (10 mg/kg) (Bayer A.G, Leverkusen, Germany). A 
5-mm piece of the middle of the colon was collected from 
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all animals in aseptic conditions in RNAlater® and kept at 
4 °C overnight before storing at −20 °C for further gene 
expression analysis by microarray.
RNA extraction
For RNA isolation, tissue samples were transferred into 
lysing matrix tubes (MP Biomedicals, Illkirch, France) 
containing an appropriate buffer and were homogenized in 
a FastPrep® instrument (MP Biomedicals) for 30 s. Lysates 
were centrifuged for 3 min at 12,000 g to eliminate excess 
tissue debris. The RNA was isolated by the RNeasy Mini 
Kit (Qiagen, Madrid, Spain) following the manufacturer’s 
recommendations and then quantified with a NanoDrop 
spectrophotometer and NanoDrop IVD-1000 v.3.1.2 soft-
ware (NanoDrop Technologies, Wilmington, DE, USA). 
The Agilent 2100 Bioanalyzer with the RNA 6000 LabChip 
kit (Agilent Technologies, Madrid, Spain) was used to pro-
vide an RNA integrity number for each sample. All sam-
ples used for further experiments showed an RNA integrity 
number (RIN) ≥ 9 and purity between 1.885 and 2.042 
using the A260/A280 ratio.
Table 1  Composition of 
nutrients and polyphenols 
provided by the three 
experimental diets (g/kg diet)
1 Total polyphenol compounds were quantified by Folin–Ciocalteu method
Components REF (g/kg) AIN-93 M C10 (g/kg) CF (g/kg) I (g/kg)
Casein 121.5 97.1 109.7 118.7
L-Cystine 1.8 1.4 1.4 1.6
Corn starch 418.1 423.7 437.2 426.4
Maltodextrin 148.5 118.7 120.4 131.5
Sucrose 102.6 108.7 110.9 110.9
Soybean oil 38.2 26.2 33.5 38.9
Cellulose 50 24.5 26.5 50.0
Minerals 35.3 27.7 27.9 31.3
Vitamins 9.1 7.2 7.2 8.1
Choline bitartrate 2.5 2.0 2.0 2.2
tert-Butylhydroquinone 0.008 0.006 0.006 0.006
Water 72.4 63 71.1 72
Cocoa powder – 100 – –
 Protein – 22 – –
 Carbohydrate – 16 – –
 Lipid – 11 – –
 Fiber (insoluble/soluble) – 34 (25.5/8.5) – –
 Minerals – 6 – –
 Total polyphenols1 – 4 – –
 Water – 7 – –
Cocoa fiber powder – – 52.3 –
 Protein – – 8 –
 Carbohydrate – – 0.5 –
 Lipid – – 4.8 –
 Fiber (insoluble/soluble) – – 31.9 (23.4/8.5) –
 Minerals – – 7 –
 Total polyphenols1 – – 0.2 –
 Water – – – –
Inulin powder – – – 8.5
 Protein – – – –
 Carbohydrate – – – –
 Lipid – – – –
 Fiber (insoluble/soluble) – – – 8.5 (−/8.5)
 Minerals – – – –
 Total polyphenols1 – – – –
 Water – – – –
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Microarray procedure
The study of the differential expression profiling was car-
ried out with a SurePrint-G3 Rat GE 8 × 60 K microar-
ray kit (ID 028279, Agilent Technologies, Madrid, Spain), 
following a loop experimental design in which a pairwise 
comparison was done. Quadruplicate samples for each 
experimental condition were employed, and dye swaps 
(Cy3 and Cy5) were performed to the RNA amplified from 
each sample. RNA quality was assessed using a TapeSta-
tion (Agilent Technologies). RNA concentration and dye 
incorporation were measured using a UV–Vis spectropho-
tometer (Nanodrop 1000, Agilent Technologies, Wilming-
ton, DE, USA). Labeling and hybridization to microarray 
were conducted following the manufacturer’s two-color 
protocol (Two-Color Microarray-Based Gene Expression 
Analysis v. 6.5, Agilent Technologies), using LowInput 
QuickAmp Labeling Kit and Agilent Microarray Hybridi-
zation Chamber Kit for labeling and hybridization, respec-
tively. Microarray chips were then washed and immedi-
ately scanned using a DNA Microarray Scanner (Model 
G2505C, Agilent Technologies) by the Genetic Diagnostic 
Bioarray facilities (Bioarray, Alicante, Spain).
Microarray data analysis
Data extraction was performed with Agilent Feature 
Extraction Software v.10.7 (Agilent Technologies). Bioin-
formatic analysis was performed with Bioconductor soft-
ware under R environment, using the following packages: 
limma (v.3.16.1) for background correction and normali-
zation, Marray and pcaMethods for quality control plots, 
RankProd for differential expression and finally GOstats 
(v.2.26.0.) and GSEABase for gene ontology functional 
analysis. Latest gene annotations available were used. Raw 
feature intensities were background-corrected using nor-
mexp background correction algorithm. Within-array nor-
malization was done using spatial and intensity-depend-
ent loess. Aquantile normalization was used to normalize 
between arrays. The expression of each gene is reported as 
the base 2 logarithm of ratio of the value obtained of each 
condition relative to control condition (REF group). A gene 
is considered differentially expressed if it displays a PFP 
(percentage of false prediction, equivalent of false discov-
ery rate, FDR) less than 0.05 by rank product nonpara-
metric method (RankProd). Venn diagrams in GX allowed 
finding differently expressed genes that followed the same 
pattern (e.g., up-regulated or down-regulated) in common 
among the experimental conditions. Finally, up- and down-
regulated genes were analyzed in terms of gene ontology 
by using a hypergeometric analysis (GOStats). The output 
of this analysis was then filtered using two different crite-
ria. On the one hand, data were filtered by fold expression, 
generating lists of differentially expressed genes by at least 
twofold, whereas on the other hand, data were filtered tak-
ing into account the statistical significance of the enrich-
ment analysis for the over and under represented GO terms 
belonging to the biological process (BP), cellular com-
ponent (CC) and molecular function (MF) domains. The 
microarray data have been lodged in the Gene Expression 
Omnibus (http://www.ncbi.nlm.nih.gov/geo/) as accession 
number: GSE7095.
Gene function analysis
Gene ontology annotation of broad terms belonging to 
the BP domain was performed using ClueGO v2.2.4 and 
Clupedia v1.2.4, a Cytoscape plugins [25, 26]. Briefly, 
gene symbols from both up- and down-regulated genes 
(Tables 2, 3, respectively) were uploaded and analyzed 
with the following default parameters: enrichment (right-
sided hypergeometric test) correction method using Bon-
ferroni step down analysis mode and showing only the 
pathways with pV ≤ 0.05; “Function” load a gene cluster 
list for Rattus norvegicus; view style setting set to “Clus-
ter”; evidenced codes set to “All”; networking specificity 
set to “medium” (GO levels 3–8); advanced term/pathway 
selection option set to 3 for the minimum genes and 4 % 
of genes for both clusters; and Kappa score threshold set 
to 0.3. A network was constructed for each pairwise com-
parison (C10 vs REF; CF vs REF and I vs REF; 3 networks 
in total). These networks provide a global view of poten-
tially relevant, interacting partners of genes with abundant 
changes. 
Validation of gene expression by real‑time PCR
Two micrograms of total RNA was converted to cDNA. 
Specific PCR TaqMan® primers and probes (Applied 
Biosystems, AB, Weiterstadt, Germany) were used to 
measure selected targets: Scgb1a1 (Rn00564903_m1, 
inventoried (I)), Scnn1 g (Rn00566891_m1, I), Fabp1 
(Rn00664587_m1, I), Serpina10 (Rn00592428_m1, I), 
Mcpt2 (Rn00756479_g1, I), Fcer1a (Rn00562369_m1, I), 
Apoa4 (Rn00562482_m1, I) and Tac4 (Rn00597278_m1, 
I). Quantitative real-time PCR assays were performed in 
duplicate for each sample using an ABI PRISM 7900HT 
Sequence Detection System (AB). Quantification of the 
genes being studied was normalized to the housekeeping 
genes Gusb (Rn00566655_m1, I). The SDS v2.4 software 
(AB) was used to analyze the expression data. Results are 
expressed as the fold change of the amount of target mRNA 
relative to the endogenous control expression calculated 
using the standard 2−∆∆Ct method for the three experimen-
tal groups relative to values from the REF group, which 
represents a onefold change in gene expression.
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Statistics
Statistical analysis of PCR results was performed using the 
software package SPSS 22.0 (SPSS, Inc.). Levene’s and 
Kolmogorov–Smirnov tests were applied to assess variance 
equality and normal distribution, respectively. Nonpara-
metric tests were performed when normal distribution and 
equality of variance did not exist. Specifically, Kruskal–
Wallis and Mann–Whitney U tests were used in order to 
assess significance for independent samples. Significant 
differences were established at P < 0.05.
Results
Body weight and chow intake
Body weight and chow intake were monitored through-
out the study. The initial body weight was similar among 
the groups (44.4 ± 0.7 g) increasing during the study up 
to 154.8 g in the REF group. In animals fed 10 % cocoa 
diet, body weight increase was lower than that in the other 
groups, the difference already being significant at day 7, 
and, at the end, the body weight was ~35 g less than that in 
the rest of the groups (P < 0.05). This effect, also observed 
in previous studies [13, 14, 27], was not related to a lower 
chow intake since this was similar in all the experimental 
groups (data not shown) throughout the study as well as in 
reported studies [13, 14, 27]. No changes in body weight 
were found due to the CF or I diets.
Colon gene expression profiles and commonly 
modulated genes
Three weeks of diet containing either 10 % cocoa, the 
equivalent amount of cocoa fiber or the equivalent amount 
of inulin as soluble fiber, produced changes in the gene 
expression of colon. The C10 group produced more 
changes than the CF and I groups, with most of these 
Table 2  List of up-regulated genes differentially expressed by ≥two-
fold with a P < 0.05 obtained after the 10 % cocoa diet intake (C10 
group) compared to the REF group (n = 4/group)
Symbol C10 vs REF CF vs REF I vs REF
log2 FC log2 FC log2 FC
Scgb1a1 3.948 1.716 1.139
Scnn1g 3.119 1.133 0.573
Fxyd4 2.583 2.089 0.718
Slc15a1 2.332 1.388 0.475
Gbp1 2.207 1.662 0.432
Cyp2f4 2.185 1.436 0.367
Dpysl4 2.069 1.387 0.242
Fmo2 2.040 1.007 0.426
Pdyn 1.873 0.194 0.175
Mt2A 1.656 0.644 −0.147
RGD1561239 1.597 1.787 0.742
Sftpd 1.583 0.163 0.351
Mme 1.580 0.636 0.353
Hoxd13 1.575 0.615 0.100
Chst5 1.533 0.591 0.082
Atp12a 1.457 1.630 0.500
Thbs4 1.450 0.908 0.302
Hoxd10 1.403 0.668 0.164
Trpv1 1.390 0.749 0.058
Hoxb13 1.358 0.786 0.101
Spink3 1.338 1.162 0.463
LOC687303 1.327 0.734 0.755
Abat 1.319 1.272 0.477
Angptl4 1.316 0.914 0.670
Aox4 1.311 0.054 0.320
B3gnt7 1.265 0.403 0.019
Pcsk9 1.253 0.048 0.063
RGD1560608 1.225 0.759 0.709
Guca2b 1.211 0.811 0.287
Padi3 1.190 0.832 0.462
Scnn1b 1.181 0.499 0.057
LOC287167 1.178 0.607 0.296
RGD1308274 1.142 0.073 0.321
Smc1b 1.133 0.968 0.031
Pde7a 1.129 0.708 0.405
LOC100363350 1.126 0.621 0.446
Gsta2 1.111 0.537 0.157
Slc20a1 1.110 0.624 0.056
RGD1310110 1.097 0.410 0.231
LOC689064 1.095 1.024 0.501
Rnase1 1.094 1.063 1.218
Dnase1 1.088 1.087 0.124
siat7D 1.058 0.363 0.096
Serpinc1 1.053 0.873 0.469
LOC494499 1.029 0.576 0.276
Fbxl13 1.028 1.009 0.067
This includes the gene symbol for all the up-regulated genes. Values 
are expressed as a log2 of fold change and shown when ≥1. Values 
for the two other experimental diets are also included, although inde-
pendently of their fold change and/or their significance. Values in 
bold and cursive represent the non-statistically significant changes
Table 2  continued
Symbol C10 vs REF CF vs REF I vs REF
log2 FC log2 FC log2 FC
Alox15 1.028 0.387 0.191
Creg1 1.021 0.406 −0.008
Rnase1l2 1.010 0.857 1.012
Alas2 1.007 0.997 0.452
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Table 3  List of down-regulated genes differentially expressed by ≥twofold with a P < 0.05 obtained after the 10 % cocoa diet intake (C10 
group) compared to the REF group (n = 4/group)
Symbol C10 vs REF CF vs REF I vs REF Symbol C10 vs REF CF vs REF I vs REF
log2 FC log2 FC log2 FC log2 FC log2 FC log2 FC
Syce2 −1.000 −1.117 0.028 Olfm4 −1.291 −0.826 0.002
Chga −1.011 −0.328 −0.133 Mt3 −1.298 −0.631 −0.372
Smpx −1.016 −0.349 −0.381 Casq2 −1.298 −0.643 −0.218
Myl2 −1.019 −0.940 −0.823 Hsd3b5 −1.302 −0.648 −0.340
Ptgis −1.026 −0.370 −0.173 Gsta5 −1.308 −0.560 −0.158
Cfd −1.037 −0.087 0.009 Pln −1.309 −0.384 −0.349
Msln −1.041 0.382 0.377 Nox1 −1.313 −0.256 0.207
LOC360228 −1.041 0.559 0.231 Me1 −1.324 −0.443 −0.264
Kcnj5 −1.043 −1.062 −0.766 Casc4 −1.334 −0.688 −0.715
Car3 −1.045 0.278 −0.263 LOC682360 −1.335 −0.459 −0.314
Slpil2 −1.050 0.102 0.425 Sln −1.360 −0.649 −0.410
Ca2 −1.055 −0.551 −0.087 RGD1563231 −1.370 −0.170 −0.580
Rgs2 −1.059 −0.856 −0.760 Slpi −1.378 0.188 0.552
Mfsd2a −1.059 −0.455 −0.262 RGD1562127 −1.382 −0.687 −0.360
Tnfrsf12a −1.059 −0.600 −1.353 Sgcg −1.386 −0.884 −0.543
Car8 −1.060 −0.525 −0.339 LOC685106 −1.390 0.215 −0.613
Mybpc2 −1.064 −0.459 −0.353 Hdc −1.393 −0.281 −0.076
Gcnt3 −1.071 −0.549 −0.183 Retnlb −1.420 1.223 1.939
Mrap −1.072 −0.045 −0.363 RGD1565374 −1.430 −0.901 −0.378
Tmprss9 −1.077 −1.024 −0.582 Apobec2 −1.436 −0.613 −0.243
Gldn −1.085 −0.522 −0.161 Sypl2 −1.457 −0.801 −0.867
Hsd3b6 −1.086 −0.518 −0.228 Fcer1a −1.497 −0.248 −0.283
Casq1 −1.086 −0.436 −0.282 Hsd17b6 −1.503 −0.988 −0.325
RGD1560314 −1.089 −0.959 −0.119 RGD1565970 −1.509 −0.198 0.413
RGD1309651 −1.094 −0.426 −0.103 Tph1 −1.518 −0.642 −0.305
Ly49i2 −1.102 −0.604 −1.177 Cfb −1.551 0.167 0.560
LOC363060 −1.108 −0.829 −0.616 Slfn3 −1.558 0.166 0.249
LOC688635 −1.113 −0.189 −0.038 Retnlg −1.560 −0.018 0.509
Kif1c −1.125 −0.943 −0.701 LOC679045 −1.562 −0.216 −0.234
LOC687842 −1.126 −0.830 −0.489 Cma1 −1.583 −0.288 0.256
Scx −1.131 −0.368 −0.413 Cpa3 −1.609 −0.258 −0.115
Slc13a1 −1.134 −0.585 −0.301 Retnla −1.627 0.878 1.162
Ccr10 −1.137 0.036 0.419 Cyp4f1 −1.634 −0.582 0.169
Mzb1 −1.140 0.064 0.772 Npc1l1 −1.662 −1.294 −0.707
Ms4a2 −1.144 −0.127 0.012 Tff1 −1.663 −0.786 −0.310
Rup2 −1.145 −1.201 −0.220 Atf3 −1.681 −1.015 −1.715
Rrad −1.150 −0.320 −0.193 Fabp1 −1.682 −0.780 −0.074
Fbln7 −1.156 −0.540 −0.398 Tnfrsf17 −1.690 −0.139 0.572
Bpifb6 −1.156 −0.825 −0.560 Spink4 −1.714 −2.376 −1.237
Cd55 −1.162 −0.438 −0.237 LOC100360169 −1.718 0.232 1.101
F2 −1.165 −0.640 −0.315 Ros1 −1.733 −1.914 −1.672
Fabp4 −1.170 −0.233 −0.334 Thrsp −1.747 −0.067 −0.380
Myom2 −1.171 −0.772 −0.257 RatNP − 3b −1.761 −2.005 −0.576
RGD1305928 −1.180 −0.851 −0.388 RGD1564563 −1.793 −0.383 −0.092
Slc18a1 −1.184 −0.791 −0.599 Mcpt8 −1.824 −0.324 0.315
Rgs1 −1.184 −0.675 −0.604 Mcpt8l3 −1.824 −0.462 0.151
Dapl1 −1.196 −0.753 −0.375 Adipoq −1.826 0.053 −0.265
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changes being down-regulated and only a few of them in 
common with the CF diet. Likewise, very few similarities 
were detected between the CF and I diets, the I group being 
the one with the fewest changes.
To show the number of genes affected in common, a 
Venn diagram representation was drawn comparing sepa-
rately the list of significantly up- and down-modified genes 
(P < 0.05) obtained for the three experimental diet groups 
of animals compared to the REF group (Fig. 1). The C10 
and CF groups shared a total of 79 modulated genes, 31 of 
which were up-regulated and 48 down-regulated. The CF 
and I groups were found to have a total of 28 modulated 
genes in common, of which 8 were up-regulated and 20 
down-regulated. Finally, a total of 18 modulated genes—3 
up-regulated and 15 down-regulated—were shared between 
the C10 and I groups. The expression of 14 genes was 
found to have been modified in common by the three 
experimental diets (3 up- and 11 down-regulated).
Focusing on the uncommon modulated genes (Fig. 1), 
the cocoa-fed animals showed the highest modulation for 
both up- and down-regulations (64 and 175, respectively), 
whereas both the cocoa fiber and inulin diets modulated a 
similar number of different genes, with the number of up- 
and down-regulated genes also being similar.
Gene ontology (GO) annotation
We have considered the most significant GO terms belong-
ing to the biological process (BP), cellular component (CC) 
This includes the gene symbol for all the down-regulated genes. Values are expressed as a log2 of fold change and shown when ≤−1. Values for 
the two others experimental diets are also included, although independently of their fold change and/or their significance. Values in bold and cur-
sive represent the non-statistically significant changes
Table 3  continued
Symbol C10 vs REF CF vs REF I vs REF Symbol C10 vs REF CF vs REF I vs REF
log2 FC log2 FC log2 FC log2 FC log2 FC log2 FC
Tmem22 −1.199 −0.583 −0.419 Mcpt9 −1.834 −0.384 0.240
Ccl12 −1.212 0.206 0.243 Mcpt4 −1.952 0.233 0.296
Siglec1 −1.213 0.130 0.102 Mcpt1 −1.966 −0.014 0.285
Fcgr3a −1.230 −0.225 0.136 Mcpt10 −1.985 −0.523 0.192
LOC686141 −1.230 −0.200 0.140 LOC100359793 −1.987 −0.141 1.137
LOC683753 −1.232 −0.795 −0.121 Scd1 −1.998 0.138 −0.400
Bhlha15 −1.233 −0.496 −0.067 Mcpt8l2 −2.003 −0.532 0.196
LOC688507 −1.238 −0.184 0.110 Pga5 −2.086 −1.394 −0.775
H19 −1.242 −0.227 −0.317 Gkn2 −2.099 −1.000 −1.584
Cxcl11 −1.260 −0.859 −0.267 Mcpt1l4 −2.170 −0.112 0.239
Rgs4 −1.262 −0.570 −0.720 RGD1562035 −2.179 −0.248 0.176
Ces2c −1.269 −0.944 −0.445 Pzp −2.223 −1.221 −1.117
Fut9 −1.270 −0.997 −0.334 Fcrls −2.342 −0.529 0.208
Srpk3 −1.272 −0.242 −0.042 Bpifb2 −2.508 −1.532 −1.300
RGD1560949 −1.273 −1.471 −1.135 Mcpt2 −2.545 −0.290 0.255
Npw −1.276 −0.777 −0.406 Tac4 −2.766 −1.731 −1.279
Rbp4 −1.283 −0.026 −0.205
Fig. 1  Differentially expressed genes among all three experimental 
groups versus REF group are visualized by means of a Venn diagram 
(n = 4/group). The diagram shows the number of genes that belongs 
to each of the individual lists, the genes in common between each 
pair of lists and the genes in common among all three lists (in the 
center of the representation) for each type of regulation (Green up-
regulation and Red down-regulation) compared to the REF group
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and molecular function (MF) domains for up- and down-
regulated genes. Criteria include both the P value together 
with the counts and the expected counts for each GO term 
in the C10 and the CF groups in comparison with the REF 
group (Tables S2 and S3, supplementary material). When 
those GO terms were also commonly enriched by the I diet, 
the number of the P value together with the counts and the 
expected counts were also included.
A functional classification, according to the BP with 
the most significant (P < 0.05) terms, was determined for 
each pairwise comparison (C10 vs REF; CF vs REF; and I 
vs REF) together for both up- and down-regulated genes as 
detailed in material and method section (Fig. 2). The first 
one shows the overrepresented GO terms by the C10 diet 
compared to the REF one (Fig. 2a). It revealed 8 functional 
subgroups which mainly contain down-regulated genes. 
Among these subgroups, cellular cation homeostasis had 
the highest number of associated genes followed by diges-
tive system process. All genes related to the regulation of 





Fig. 2  Common BP belonging to the most significantly overrep-
resented GO terms for the analyzed clusters. In red are shown the 
percentages of Cluster 1 (down-regulated) genes associated with the 
most significant (P < 0.05) overrepresented biological process GO 
terms and in green the percentages of Cluster 2 (up-regulated) genes 
associated with these most significant overrepresented biological pro-
cess GO terms
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genes). The second comparison was between rats fed with 
the CF diet and those fed with the REF diet (Fig. 2b). 
When animals were fed the CF, only one functional sub-
group (digestive system process) was obtained which only 
contains down-regulated genes. Similarly, a unique func-
tional category (regulation of digestive system process) 
containing down-regulated genes appeared when the over-
represented in the up- and down-regulated genes by I diet 
were compared to the reference group (Fig. 2c).
Analysis of biological processes
For each one of the comparison discussed above, ClueGO 
and CluePedia were used to create networks employing all 
the interactions found between them including the over-
represented BP GO terms in both up- and down-regulated 
genes (Fig. 3). The network obtained after comparing the 
C10 and the REF groups was the one with the highest com-
plexity due to the interactions among the different BP. All 
these interactions were among overrepresented categories 
in down-regulated genes (Fig. 3a). The digestive system 
process had the most significant enrichment, followed by 
the cellular cation homeostasis term. Moreover, the diges-
tive system process closely related to the intestinal absorp-
tion term.
When the CF and REF groups were compared (Fig. 3b), 
the obtained network revealed that the digestive system 
process category was the only significant GO biological 
process obtained. From the considered dataset, all biologi-
cal processes belonging to this category presented similar 
significant enrichment. All the obtained interactions were 
among overrepresented categories in down-regulated genes.
The simplest network was obtained after comparing I 
and REF groups. It showed that the regulation of digestive 
system process was the only significant overrepresented 
category obtained in down-regulated genes.
No significant overrepresented GO terms for up-regu-
lated genes were observed in any comparisons.
Impact of cocoa diet on gene expression
An extensive number of genes were both up- and down-reg-
ulated after the C10 and CF diets (Table S1, supplementary 
material). However, given that the main aim of the present 
study was to elucidate the mechanism by means of which 
cocoa intake modulates the immune response and the lipid 
metabolism, the “Results” and “Discussion” sections of the 
present work are mainly focused in those modulated genes 
belonging to these two pathways.
The ≥twofold up- and down-regulated genes expression 
after cocoa diet intake (C10 group) compared to the REF 
group is shown in Tables 2 and 3, respectively. Likewise, 
the fold change expression of the same genes by the CF and 
I diets is included. The two genes with the highest fold up-
regulation after C10 diet were Scgb1a1 and Scnn1 g (3.948 
and 3.119 log fold change, respectively) (Table 2), the first 
one encoding a small epithelium-derived protein related to 
anti-inflammation, and the second one the gamma subunit 
of a membrane-bound ion channel which plays an essen-
tial role in electrolyte (basically sodium transport in kidney, 
colon, lung and sweat glands) and blood pressure homeo-
stasis. If we consider GO terms, the most up-regulated 
genes in the C10 group (Scgb1a1, Cyp2f4, Dpysl4, Fmo2, 
Hoxd10, Spink3, Angptl4, Padi3, Pde7a, Creg1 and Alas2) 
(Table 2) belong to the metabolic process (including total, 
primary and cellular processes, GO:0008152, GO:0044238 
and GO:0044237, respectively, in BP domain) and the 
binding pathways (GO:0005488 in MF domain) terms, 
respectively. Moreover, the most significantly enriched up-
regulated GO terms are also represented here. Particularly, 
Mt2A, Sftpd, Atp12a, Trpv1, Angptl4, Guca2b, Alox15 and 
Alas2 belong to the response to inorganic substance term 
(GO:0010035 in BP domain), whereas most of the sig-
nificantly enriched up-regulated GO terms (GO:0019825, 
GO:0020037, GO:0046906, GO:0005506, GO:0022892) in 
the MF domain are represented by the Cyp2f4, LOC287167, 
LOC689064, Alox15, Alas2, Scnn1 g and Fxyd4.
On the other hand, the most up-regulated genes after CF 
and I diet intake were Fxyd4 (a protein-coding gene mem-
ber of a family of small membrane proteins) and Vom2r3 (a 
protein-coding gene involved in G protein-coupled recep-
tor signaling pathway), respectively. The last gene did not 
undergo a twofold changed by 10 % cocoa diet (Table S1, 
supplementary material).
The gene with the highest down-regulation after the 
C10 group was Tac4 (tachykinin 4), a member of the 
tachykinin family of neurotransmitter peptides involved in 
the immune system regulation, which decreased by 2.766 
(Table 3). This gene and other genes down-regulated by 
10 % cocoa diet are related to the immune system. Some 
others are the Fcer1a (log2 FC −1.497) encoding the 
expression of the high-affinity receptor I for IgE Fc frag-
ment for alpha polypeptides, and Ms4a2 (log2 FC −1.144) 
encoding the same receptor for beta polypeptides. Both 
genes, together with Tac4, are implicated in pathways 
related to the mast cell-mediated immunity (GO:0002448), 
its activation (GO:0045576, GO:0002279, GO:0033008, 
GO:0033005, GO:0033006, GO:0033003) and its degranu-
lation (GO:0043303, GO:0043304, GO:0043306) in the BP 
domain. Fcer1a and Ms4a2, acting together with Fcgr3a 
(log2 FC −1.230), are also involved in the immunoglobu-
lin binding pathway (GO:0019865 in the MF domain) and, 
together with Adipoq (log2 FC −1.826), are involved in 
cytokine production (GO:0001816 in the BP domain).
In addition, in C10 group a great number of down-regu-
lated genes, such as Adipoq, Fabp1, Fabp4, Fcer1a, Ptgis, 
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Cyp4f1 and Npc1ǀ1, affect the lipid and fatty acid metabolic 
process pathways (GO:0006629 and GO:0006631 in the BP 
domain, respectively). Many other genes down-regulated 
by 10 % cocoa diet are involved in the proteolysis pathway 
such as Mcpt1, Mcpt2, Mcpt4, Mcpt8, Mcpt10 and Pga5 
(GO:0006508 in the BP domain); response to stress such 
as F2, Cd55, Nox1, Fcer1a, Tph1 and Tff1 (GO:0006950 




Fig. 3  Biological processes network according to ClueGO (only 
overrepresented categories in down-regulated genes are found). Over-
represented BP GO terms are represented as nodes, and the nodes 
size represents the term enrichment significance by the Bonferroni 
step down method, linked by their Kappa score level (≥0.30). Edges 
represent connections between the nodes and the length of each edge 
reflects the relatedness of two processes. Only the labels of the most 
significant terms (P < 0.05) are shown
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Tnfrsf12a, Casq1, Smpx and Fcgr3a, (GO:0005886 in the 
CC domain); and protein binding such as Retnlg, Fabp4, 
Npw, Myl2, and Bhlha15 (GO:0005515 in the MF domain).
Most of these genes highly modified by the cocoa diet 
were not or were only slightly modified in the CF and I 
groups with the exception of Ros1 (an orphan receptor 
tyrosine kinase that plays a role in cell differentiation) and 
Tac4, which were also modified in the CF-fed animals, 
and Atf3 (activating transcription factor 3) and Retnlb (a 
cysteine-rich cytokine expressed in the colon and impli-
cated in immunity) in the I-fed animals.
The CF and I diets down-regulated more than twofold 
the expression of Serpina10 (log2 FC −2.729 and −2.987, 
respectively), a gene codifying a serpin family member 
predominantly expressed in the liver and involved in the 
regulation of the coagulation factors’ activity, and Apoa4 
(log2 FC −1.955 and −1.273, respectively), a protein-
coding gene that plays a role in lipoprotein metabolism 
(Table S1, supplementary material). On the contrary, these 
genes were not so affected by 10 % cocoa diet (log2 FC 
0.475 and −0.645, respectively) (Table S1, supplementary 
material).
Validation of microarray results by Real‑Time PCR 
analysis
Eight genes representative of the affected pathways and 
with differential expression were selected for further analy-
sis and validation of microarray results using quantitative 
RT-PCR. The studied genes included Scgb1a1, Scnn1 g 
(highly up-regulated in the C10 group), Tac4, Mcpt2, 
Fcer1a and Fabp1 (highly down-regulated in the C10 
group). In addition, Serpina10 (highly down-regulated in 
both the CF and I groups) and Apoa4 (highly down-regu-
lated in the CF group) were also studied.
Results are shown in Fig. 4, where the fold change 
expression determined both in the microarray and by PCR 
for each gene in each group is summarized. The quantita-
tive PCR results are consistent with that of microarray. 
Although not all changes by PCR achieved statistical sig-
nificance, a similar pattern of expression was determined 
using both techniques (Fig. 4). The statistical analysis of 
the real-time PCR results showed that only the expression 
of Mcpt2 (P = 0.01) and Fcer1a (P = 0.01) was signifi-
cantly down-regulated in the C10 group and that the cocoa 
Fig. 4  Expression of selected 
genes by real-time PCR. The 
values are presented as fold 
change in comparison with the 
REF group that is considered 1 
(n = 10/group). Filled bars rep-
resent the expression for each 
specific gene as determined in 
the microarray experiments, and 
empty bars represent the expres-
sion for each specific gene as 
determined by PCR normalized 
by Gusb. Statistical signifi-
cance: *P < 0.05 vs REF group; 
α P < 0.05 vs C10 group
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fiber diet produced a significant down-regulation of Ser-
pina10 expression (P = 0.04).
Discussion
We have previously reported that the intake of a 10 % cocoa 
diet in young rats induces changes in body weight and in 
the intestinal environment modulating the gut immune sys-
tem and microbiota composition [13]. The involvement of 
cocoa fiber in such effects as well as its precise mechanism 
of action is unknown to date. In the present study, a micro-
array of the colon tissue RNA allowed the in-depth study 
of the modifications of gene expression induced in rats by 
either a 10 % cocoa diet or two other diets with the same 
proportion of soluble and insoluble fibers: one based on 
cocoa fiber and the other containing inulin.
Although the three experimental diets up- or down-reg-
ulated a large number of genes, the cocoa intake caused the 
most pronounced and numerous changes. The C10 diet was 
the one which resulted in a higher number of significantly 
overrepresented GO terms, with most of their genes being 
down-regulated. Moreover, there were much more inter-
actions between the enriched GO terms after the C10 diet 
intake than those obtained after CF and I diets, with most 
of these interactions being among down-regulated genes.
A group of genes down-regulated by cocoa intake 
allowed us to study in-depth the mechanisms of this diet 
and its involvement in the immune function. In fact, the 
most down-regulated gene in the C10 group was that of 
tachykinin 4 (Tac4), which has been described as the pro-
moter of B lineage cells [28]. As B lymphocytes are the 
immune cells responsible for antibody synthesis, these 
results could explain previous studies showing the cocoa-
induced attenuation of immunoglobulin concentration in 
rats in both the systemic and intestinal compartments [15, 
27, 29, 30]. This gene modification could also be respon-
sible, at least partially, for the decrease in IgE synthesis in 
allergic animals induced by the 10 % cocoa diet [10] and 
even for the same effect reported by other polyphenols [31]. 
Focusing on allergy, it seems that cocoa intake could also 
be beneficial in aspects other than IgE synthesis because, 
as shown here, it down-regulates the expression of genes, 
such as Fcer1a, Ms4a2 and Tac4, involved in several GO 
terms related to mast cell-mediated immunity, its activa-
tion and its degranulation, key events in allergic response. 
When considering the expression of these immune-related 
genes in the cocoa fiber and inulin groups, the effects were 
not so marked, and therefore, this may suggest that poly-
phenols or other cocoa compounds, but not cocoa fiber, are 
mainly responsible for the immunomodulatory properties 
of cocoa by interfering in the B cell ability to produce anti-
bodies and also in the mast cell functionality.
A cocoa diet might also exert its immunomodulatory 
effects through the down-modulation of the expression of 
genes involved in cytokine production (Fcer1a, Ms4a2 and 
Adipoq). In addition, cocoa diet in rats has demonstrated 
certain protective effects against chronic inflammation [32, 
33] that could also be related to the down-regulation of the 
cytokine gene expression and also to the up-regulation of 
the expression of Scgb1a1, the gene that codifies a protein 
related to anti-inflammation [34]. In this context, both fiber 
diets—of cocoa and inulin—also increased the Scgb1a1 
gene expression, although in a lower intensity compared to 
that observed in the C10 group, suggesting that fiber is par-
tially responsible for the anti-inflammatory effect of cocoa 
but that other cocoa compounds such as flavonoids must 
also be involved [35]. However, contrary to this sugges-
tion, a significant down-regulation of Scgb1a1 gene expres-
sion has been found in a lung tumor mice model treated for 
20 weeks with green tea [36].
Another group of genes down-regulated by the 10 % 
cocoa diet was related to the lipid metabolism. In par-
ticular, the expression of Adipoq, an adipocyte-derived 
hormone involved in glucose and lipid metabolism, and 
Fabp1, an acid-binding protein found in liver, intestine 
and kidney involved in fatty acids uptake, transport and 
metabolism, was decreased by 1.826 and 1.682 FC loga-
rithms. Moreover, the expression of Angptl4, a circulating 
lipoprotein lipase inhibitor, was up-regulated in the C10 
group. Since these genes were less affected by the CF and 
I diets, we can suggest that the cocoa diet modifies lipid 
metabolism and this effect cannot be totally attributed to its 
fiber content and cocoa flavonoids are probably involved. 
The results agree with the reported hypolipidemic capacity 
of a cocoa diet [37–40] as well as in line with the results 
obtained, here and also in previous studies, on body weight 
[13, 27, 30, 41, 42]. In fact, the down-regulation of genes 
related to lipid metabolism has also been described by fla-
vonoids, such as quercetin. The administration of querce-
tin in mice fed with a high-fat diet reduces the expression 
of hepatic genes related to lipid and fatty acid production, 
such as Aldh1b1, Abcg5, Acaca, Fasn, Gpam and Apoa4 
[38]. Although some other studies report body weight loss 
and a reduced fat deposition after polyphenol intake [38, 
43, 44], previous studies carried out in our laboratory using 
three distinct cocoa materials with different proportions of 
polyphenols suggest that those effects on body weight can-
not be exclusively attributed to cocoa polyphenols but also 
to other compounds present in cocoa [29]. As in the pre-
sent study, we evidenced the lack of effect of the CF diet on 
body weight and on the same genes related to lipid metab-
olism as the entire cocoa diet, other bioactive compounds 
of cocoa, such as methylxanthines, could be proposed as 
being responsible for these effects on lipid metabolism 
gene expression proteins and body weight. In this context, 
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methylxanthines are effective in stimulating resting energy 
expenditure per se [45] as well as regulating the lipid pro-
file in obese–diabetic rats [46]. In addition, the synergistic 
interactions between methylxanthines and flavonoids in the 
thermogenesis have been suggested which could explain 
their effect on body weight [45].
Regarding cocoa fiber, in spite of the fact that it did 
not show the effects on the same lipid metabolism genes 
as cocoa, it is worth noting that the CF diet down-regu-
lated the expression of another gene related to lipoprotein 
metabolism, the Apoa4. As also validated by RT-PCR, all 
three experimental diets down-regulated this gene, but the 
highest effect was observed after CF intake. These results 
could justify the hypolipidemic effect reported after con-
sumption of either insoluble or soluble CF. In this context, 
the modulation of serum and liver lipid profile has been 
reported both in rats fed insoluble CF [18] and those fed 
soluble CF [19, 20]. Apoa4 can also be associated with the 
response to superoxide and to oxygen radical pathways 
(GO:0000303 and GO:0000305, respectively); therefore, 
its down-regulation could elucidate the mechanism by 
which CF and cocoa flavanols are able to diminish the lev-
els of certain lipid peroxidation biomarkers [39, 47]. From 
our results, we can also observe the cocoa effects on other 
genes associated with the antioxidant activity [39]. Thus, a 
significant increase in the expression of Hba-a2 and Hbb 
genes, encoding alpha and beta betaglobin subunits, respec-
tively, was found in both the C10 group and the CF group, 
although the influence was lower than a twofold change.
Another beneficial effect of cocoa intake concerns blood 
pressure. Cocoa flavanols have been described to pos-
sess antihypertensive properties [48], which have made 
them a subject matter of health claims by the European 
Food Safety Authority [49]. Possible feasible mecha-
nisms whereby they decrease blood pressure could either 
be maintaining the endothelium-dependent vasodilata-
tion [50], or inhibiting the angiotensin-converting enzyme 
(ACE) activity [51]. Partially in line with those mecha-
nisms, in our study, a significant decrease in the expression 
of Mcpt1 and Mcpt4—both genes involved in the regula-
tion of systemic arterial blood pressure by renin–angioten-
sin (GO:0003081)—have been observed in 10 % cocoa-fed 
animals but not in the CF group. Nevertheless, the expres-
sion of the Scnn1 g gene, involved in blood pressure home-
ostasis, was up-regulated in the C10 group and also in the 
CF animals, although with a <twofold change. In addition, 
both the CF diet and the inulin diet down-regulated by more 
than twofold the expression of Serpina10, a gene involved 
in the regulation of the coagulation factors’ activity, whose 
deficiency has been related to the risk of thrombosis [52]. 
Overall, our results show that cocoa intake modifies some 
colonic genes related to blood pressure regulation, and 
these effects cannot be attributed to its fiber content.
It remains to be elucidated which component from 
cocoa, but not cocoa fiber, is the main responsible for these 
changes in gene expression: both flavonoids and theobro-
mine, present in high proportion in cocoa, are good candi-
dates for such effects.
In summary, this study sheds light on the mechanisms 
involved in the reported effects of cocoa intake. As shown 
here, cocoa consumption down-regulates some genes 
related to the immune system (B cell and mast cell func-
tionality), to lipid metabolism and also to blood pressure 
in the colon tissue. In addition, after comparing the effects 
of cocoa in its entirety and those produced by only cocoa 
fiber, it can be concluded that most of the beneficial effects 
attributed to cocoa are not only due to its fiber content but 
that polyphenols and other compounds could also be key 
factors.
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